Rebate economics, spread, administrative fees, and pass-through pricing are not something most finance leaders ramp into. They are the economics I work in. CFO advisory for pharmacy benefit managers, rebate aggregators, and the data and services businesses built around them.
Pharmacy benefit management runs on economics that do not look like any other industry. Revenue is layered across administrative fees, rebate retention, spread, and increasingly pass-through arrangements where the margin moves to service and data. A finance leader who has not lived inside those mechanics spends the first two quarters learning the vocabulary instead of running the business.
That ramp is expensive. In a market where plan sponsors, consultants, and regulators are all pushing toward transparency, the CFO seat has to model the difference between a traditional spread book and a transparent pass-through book in real terms... what it does to gross margin, to cash timing on rebate receivables, and to the multiple a buyer will pay. That is not a textbook exercise. It is pattern recognition built from running the numbers.
This is acting CFO and CFO advisory work, scoped to the situation rather than billed by the hour. The common threads in PBM and PBM-adjacent engagements:
The fit is founder-led or PE-backed companies, generally in the $5M to $100M revenue range, where finance has to lead rather than just report. That includes standalone PBMs, rebate aggregators, specialty and mail-order pharmacy businesses, and the technology and data companies that sell into them. Common trigger moments: a capital raise, a recapitalization, exit preparation, a turnaround under cash or margin pressure, or post-close value creation under new ownership.
If the business is below that range but the founder knows something in the financial picture is off, the right first step is usually a Pulse Check... a fixed-fee, 30-day diagnostic on cash, margin, and KPI maturity that produces a prioritized action memo. It is the lowest-risk way to get a senior read before committing to anything larger.
This is not bookkeeping, controllership, or claims operations. It is the strategic finance seat... the person who sits between the CEO, the board, and a future buyer and makes sure the numbers tell a story that is both true and defensible.
The questions that come up first when a founder or sponsor is sizing up the fit.
A 30-minute call is enough to tell whether the fit is real. No pitch deck, no obligation... just a direct read on where finance can take the business next.